These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 18000791)

  • 1. The role of tissue factor pathway inhibitor-2 in cancer biology.
    Sierko E; Wojtukiewicz MZ; Kisiel W
    Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure, function and biology of tissue factor pathway inhibitor-2.
    Chand HS; Foster DC; Kisiel W
    Thromb Haemost; 2005 Dec; 94(6):1122-30. PubMed ID: 16411383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of tissue factor pathway inhibitor 2 inversely correlates during the progression of human gliomas.
    Rao CN; Lakka SS; Kin Y; Konduri SD; Fuller GN; Mohanam S; Rao JS
    Clin Cancer Res; 2001 Mar; 7(3):570-6. PubMed ID: 11297250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory properties of a novel human Kunitz-type protease inhibitor homologous to tissue factor pathway inhibitor.
    Petersen LC; Sprecher CA; Foster DC; Blumberg H; Hamamoto T; Kisiel W
    Biochemistry; 1996 Jan; 35(1):266-72. PubMed ID: 8555184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EGCG inhibits growth and induces apoptosis in renal cell carcinoma through TFPI-2 overexpression.
    Gu B; Ding Q; Xia G; Fang Z
    Oncol Rep; 2009 Mar; 21(3):635-40. PubMed ID: 19212621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix localization of tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor (TFPI-2/MSPI) involves arginine-mediated ionic interactions with heparin and dermatan sulfate: heparin accelerates the activity of TFPI-2/MSPI toward plasmin.
    Liu Y; Stack SM; Lakka SS; Khan AJ; Woodley DT; Rao JS; Rao CN
    Arch Biochem Biophys; 1999 Oct; 370(1):112-8. PubMed ID: 10496984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel function of tissue factor pathway inhibitor-2 (TFPI-2) in human glioma invasion.
    Konduri SD; Rao CN; Chandrasekar N; Tasiou A; Mohanam S; Kin Y; Lakka SS; Dinh D; Olivero WC; Gujrati M; Foster DC; Kisiel W; Rao JS
    Oncogene; 2001 Oct; 20(47):6938-45. PubMed ID: 11687973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of tissue factor pathway inhibitor in tumor growth and metastasis.
    Amirkhosravi A; Meyer T; Amaya M; Davila M; Mousa SA; Robson T; Francis JL
    Semin Thromb Hemost; 2007 Oct; 33(7):643-52. PubMed ID: 18000790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tissue factor pathway inhibitors].
    Sierko E; Zawadzki RJ; Wojtukiewicz MZ
    Pol Merkur Lekarski; 2002 Jul; 13(73):66-9. PubMed ID: 12362512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prokaryotic expression, purification, and reconstitution of biological activities (Antiprotease, antitumor, and heparin-binding) for tissue factor pathway inhibitor-2.
    Rao CN; Reddy P; Reeder DJ; Liu Y; Stack SM; Kisiel W; Woodley DT
    Biochem Biophys Res Commun; 2000 Oct; 276(3):1286-94. PubMed ID: 11027624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus-mediated expression of tissue factor pathway inhibitor-2 inhibits endothelial cell migration and angiogenesis.
    Ivanciu L; Gerard RD; Tang H; Lupu F; Lupu C
    Arterioscler Thromb Vasc Biol; 2007 Feb; 27(2):310-6. PubMed ID: 17138934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of tissue factor pathway inhibitor-2 (TFPI-2), decreases the invasiveness of prostate cancer cells in vitro.
    Konduri SD; Tasiou A; Chandrasekar N; Rao JS
    Int J Oncol; 2001 Jan; 18(1):127-31. PubMed ID: 11115549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of tissue factor pathway inhibitor 2 in human pancreatic carcinoma and its effect on tumor growth, invasion, and migration in vitro and in vivo.
    Tang Z; Geng G; Huang Q; Xu G; Hu H; Chen J; Li J
    J Surg Res; 2011 May; 167(1):62-9. PubMed ID: 20018303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of serine proteinase inhibitor PP5/TFPI-2/MSPI decreases the invasive potential of human choriocarcinoma cells in vitro and in vivo.
    Jin M; Udagawa K; Miyagi E; Nakazawa T; Hirahara F; Yasumitsu H; Miyazaki K; Nagashima Y; Aoki I; Miyagi Y
    Gynecol Oncol; 2001 Nov; 83(2):325-33. PubMed ID: 11606093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth suppression of human laryngeal squamous cell carcinoma by adenovirus-mediated tissue factor pathway inhibitor gene 2.
    Sun Y; Xie M; Liu M; Jin D; Li P
    Laryngoscope; 2006 Apr; 116(4):596-601. PubMed ID: 16585865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a human TFPI-2 splice variant that is upregulated in human tumor tissues.
    Kempaiah P; Chand HS; Kisiel W
    Mol Cancer; 2007 Mar; 6():20. PubMed ID: 17352822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of tissue factor pathway inhibitor-2 in ovarian tumor migration and invasion].
    Zhong R; Huang RB; Song SJ
    Ai Zheng; 2003 Oct; 22(10):1038-41. PubMed ID: 14558946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tissue factor pathway inhibitor-2 induces caspase-mediated apoptosis in a human fibrosarcoma cell line.
    Kempaiah P; Kisiel W
    Apoptosis; 2008 May; 13(5):702-15. PubMed ID: 18401718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of tissue factor pathway inhibitor (TFPI) in human breast and colon cancer tissue.
    Sierko E; Wojtukiewicz MZ; Zimnoch L; Kisiel W
    Thromb Haemost; 2010 Jan; 103(1):198-204. PubMed ID: 20062932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.